Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.

Popular medications approved for weight loss, diabetes, and heart disease may have health benefits beyond weight loss, and blood sugar control, but there are risks too.

“I’m making money to afford semagultide,” Rice, 42, who works three jobs to afford the expensive injectables, explained to her over 14,000 TikTok fans . Classified as a GLP-1, appetite-suppressing ...

If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

ImmunoPrecise has outperformed the broader market in a spectacular fashion. As of now, IPA’s YTD performance stands at +81.64%, a staggering increase compared to the S&P 500’s YTD performance of just ...

Medifast, Inc. MED, a prominent player in the health and wellness industry, is making significant strides to expand its ...

Only 34 of 79 websites stated that compounded drugs were not FDA approved; 39 websites did not report adverse effects, warnings.

Oikos and its other popular brands are seeing a spike in demand as people taking the weight-loss medications turn to the portion-controlled snacks to meet their nutritional needs.

Fierce Healthcare is tracking workforce changes across healthcare in 2025. Stick with this tracker for the latest updates, ...

In today’s health headlines, the 175 health benefits and risks of taking GLP-1 drugs. Also, many older adults don’t realize they meet the criteria for a dementia ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...